01—Abstract
Summary
Summary of the 8-K filed August 28, 2026. Cited figures are marked; the original filing is the authoritative source.
Labcorp Holdings Inc. (NYSE: LH) furnished a Form 8-K under Item 7.01 (Regulation FD Disclosure) on August 28, 2026, announcing that members of its executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 11:30 a.m.
ET. The filing is an informational notice rather than a financial or operational disclosure, and it contains no financial results, guidance, or new material business developments. A live audio webcast of the fireside chat will be available through the Labcorp Investor Relations website at ir.labcorp.com, and the webcast will be archived for replay for 180 days following the event.
The accompanying press release (Exhibit 99.1), dated August 28, 2026, is furnished and incorporated by reference, and it describes Labcorp as a global leader of innovative and comprehensive laboratory services. The boilerplate in the press release states that Labcorp has nearly 71,000 employees, serves clients in approximately 100 countries, supported more than 85%a of the new drugs and therapeutic products approved by the FDA in 2025, and performed more than 750 million tests for patients worldwide. For investors, the filing's primary relevance is the opportunity to hear management commentary at the conference and to access the replay.
02—Key points
Key Highlights
- Labcorp Holdings Inc. (NYSE: LH) filed an 8-K under Item 7.01 (Regulation FD Disclosure) on August 28, 2026, announcing executive management participation in a conference.
- Executive management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 11:30 a.m. ET.
- A live audio webcast will be available via the Labcorp Investor Relations website at ir.labcorp.com.
- The webcast will be archived for replay for 180 days following the event.
- The filing contains no financial results, earnings guidance, or new operational disclosures.
- Exhibit 99.1 is a press release dated August 28, 2026, furnished and incorporated by reference.
- Company boilerplate cites nearly 71,000 employees, service to clients in approximately 100 countries, support for more than 85% of FDA-approved new drugs and therapeutic products in 2025, and more than 750 million tests performed.
03—Questions
Frequently Asked Questions
What event is Labcorp announcing in this filing?
Members of Labcorp's executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 11:30 a.m. ET.
How can investors access the fireside chat?
A live audio webcast will be available via the Labcorp Investor Relations website at ir.labcorp.com, and it will be archived for replay for 180 days following the event.
Does this filing include financial results or guidance?
No. The filing is a Regulation FD disclosure announcing the conference appearance and does not contain financial results, guidance, or other financial figures.
What is the purpose of Exhibit 99.1?
Exhibit 99.1 is a press release dated August 28, 2026, issued by Labcorp Holdings Inc. announcing the fireside chat. It is furnished and incorporated by reference into the filing.
What scale does Labcorp describe for its business?
The press release boilerplate states Labcorp has nearly 71,000 employees, serves clients in approximately 100 countries, supported more than 85% of new drugs and therapeutic products approved by the FDA in 2025, and performed more than 750 million tests for patients around the world.
04—Continue